REGULATED PRESS RELEASE published on 04/08/2025 at 08:30, 1 year 7 months ago Cie du Bois Sauvage: Buy back of own shares – week from 31/03/2025 to 04/04/2025 Cie du Bois Sauvage disclosed its share buy-back transactions from 31/03/2025 to 04/04/2025, totaling 544 shares purchased for €129,574.00. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Share Buy-back NYSE Euronext Market Brussels Trading Regulation
REGULATED PRESS RELEASE published on 04/08/2025 at 08:15, 1 year 7 months ago Publication of the CNP Assurances Group and CNP Assurances SA Solo SFCRs at 31 December 2024 CNP Assurances Group and CNP Assurances SA release the solo SFCRs for 31 December 2024, meeting Solvency II requirements. Key points include SCR coverage ratios and financial data CNP Assurances Regulatory Compliance Financial Report SFCR Solvency
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Transaction in Own Shares Molten Ventures plc announces transaction in own shares as part of share repurchase program. Numis Securities bought 70,000 Ordinary Shares, highest price 235.00p, lowest 215.60p Ordinary Shares Molten Ventures Plc Numis Securities Share Repurchase Program Price
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Pulsar Helium Announces Execution of US$4 Million Project Finance Facility Line of Credit Note Pulsar Helium Inc. secures US$4 million project finance facility for Topaz Helium project in Minnesota from University Bancorp, Inc Pulsar Helium Inc. Topaz Helium Project Minnesota Finance Facility University Bancorp
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Quantum Genomics provides an update on its situation Quantum Genomics provides an update on trading suspension, search for a new business partner, and financial situation with impending yearly accounts release Financial Situation Trading Suspension Quantum Genomics Reverse Take Over Yearly Accounts Release
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital University Hospital Zurich conducts independent study on Steriwave for preoperative nasal decolonization, assessing efficacy in reducing microbial burden to combat surgical site infections (SSI) Nasal Decolonization Steriwave Clinical Study University Hospital Zurich Antimicrobial Photodynamic Therapy
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 7 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago Nyxoah Provides Update on FDA Approvable Letter for Genio System Nyxoah provides update on FDA Approvable Letter for Genio System, expecting full PMA approval in Q2 2025 after addressing final requirements FDA Nyxoah Genio System Approvable Letter PMA Approval
Published on 11/14/2026 at 01:30, 5 hours 2 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 5 hours 52 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 5 hours 57 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 6 hours 32 minutes ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:15, 7 hours 17 minutes ago Core Critical Metals Corp. Announces $500,000 Non-Brokered Critical Mineral Flow-Through Private Placement
Published on 11/13/2026 at 23:24, 7 hours 7 minutes ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 8 hours 39 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 11 hours 23 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 18:04, 12 hours 27 minutes ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Published on 11/13/2026 at 11:35, 18 hours 57 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/12/2026 at 23:12, 1 day 7 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 1 day 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 1 day 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 17:40, 1 day 12 hours ago Financial information for the period ended 30 September 2026
